BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 29518025)

  • 1. Emerging Roles of p53 Family Members in Glucose Metabolism.
    Itahana Y; Itahana K
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
    Hall C; Muller PAJ
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dominant-negative interplay between p53, p63 and p73: A family affair.
    Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
    Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor p53 and metabolism.
    Liu J; Zhang C; Hu W; Feng Z
    J Mol Cell Biol; 2019 Apr; 11(4):284-292. PubMed ID: 30500901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor p53 and its mutants in cancer metabolism.
    Liu J; Zhang C; Hu W; Feng Z
    Cancer Lett; 2015 Jan; 356(2 Pt A):197-203. PubMed ID: 24374014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor.
    Madan E; Gogna R; Bhatt M; Pati U; Kuppusamy P; Mahdi AA
    Oncotarget; 2011 Dec; 2(12):948-57. PubMed ID: 22248668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ∆Np73 is capable of inducing apoptosis by co-ordinately activating several BH3-only proteins.
    Sánchez-Carrera D; García-Puga M; Yáñez L; Romón Í; Pipaón C
    Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the p53 tumor suppressor in metabolism and diabetes.
    Kung CP; Murphy ME
    J Endocrinol; 2016 Nov; 231(2):R61-R75. PubMed ID: 27613337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Evolution and Dynamics of the p53 Proteins.
    Chillemi G; Kehrloesser S; Bernassola F; Desideri A; Dötsch V; Levine AJ; Melino G
    Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 27091942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumor suppressor p53 in metabolism and energy regulation, and its implication in cancer and lifestyle-related diseases.
    Hashimoto N; Nagano H; Tanaka T
    Endocr J; 2019 Jun; 66(6):485-496. PubMed ID: 31105124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis.
    Tashakori M; Zhang Y; Xiong S; You MJ; Lozano G
    Mol Cancer Res; 2016 Jan; 14(1):56-65. PubMed ID: 26527653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 family members have distinct roles during mammalian embryonic development.
    Van Nostrand JL; Bowen ME; Vogel H; Barna M; Attardi LD
    Cell Death Differ; 2017 Apr; 24(4):575-579. PubMed ID: 28211873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP.
    Roberts O; Paraoan L
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188393. PubMed ID: 32679166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
    Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
    Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism.
    Nemajerova A; Amelio I; Gebel J; Dötsch V; Melino G; Moll UM
    Cell Death Differ; 2018 Jan; 25(1):144-153. PubMed ID: 29077094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner.
    Cai BH; Bai ZY; Lien CF; Yu SJ; Lu RY; Wu MH; Wu WC; Chen CC; Hsu YC
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Backbone resonance assignments of the human p73 DNA binding domain.
    Cino EA; Soares IN; Freitas MS; Silva JL
    Biomol NMR Assign; 2016 Apr; 10(1):49-51. PubMed ID: 26294377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data.
    Sbisà E; Catalano D; Grillo G; Licciulli F; Turi A; Liuni S; Pesole G; De Grassi A; Caratozzolo MF; D'Erchia AM; Navarro B; Tullo A; Saccone C; Gisel A
    BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S20. PubMed ID: 17430565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TUMOR MICROENVIRONMENT REGULATION BY HYPOXIA-INDICIBLE FACTORS (HIFs), AND p53 FAMILY PROTEINS.
    Petrova VS; Barlev NA
    Tsitologiia; 2017; 59(4):259-70. PubMed ID: 30188089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.